Stem Cell Agency Awards $39 Million [California]
By Los Angeles Times,
Los Angeles Times
| 09. 10. 2005
California's stem cell research agency awarded the first of a planned $3 billion in grants Friday, announcing that a little less than $39 million would go to UCLA, UC Irvine, Stanford and several other campuses to help set up programs to train scientists.
Although the amount was relatively small, competition among 26 universities and nonprofit institutions was stiff because those selected hope to be at the front of the line for more lucrative public financing to come.
The agency's Independent Citizens' Oversight Committee chose 16 winners.
The agency, the California Institute for Regenerative Medicine, was set up by Proposition 71, which voters passed last year to fund a program of research using embryonic stem cells to develop potential treatments for disease.
For now, the institute doesn't have any of its own money to give out. Lawsuits filed by anti-tax and antiabortion groups have blocked the state from issuing the bonds that Proposition 71 authorized.
As a result, the agency's chairman, Robert Klein, has been asking private philanthropic groups to fill the void with the expectation that they will be repaid...
Related Articles
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Ed Pilkington, The Guardian | 06.12.2026
Desperate US parents paying up to $20,000 a session for a procedure scientists say could be bogus
Autistic children as young as 18 months old are being injected with human stem cells derived from umbilical cords in unapproved, unproven and...
By Tobi Thomas, The Guardian | 06.10.2026
The UK’s stem cell transplant system is potentially putting the lives of blood cancer patients at risk as a result of inadequate infrastructure and a lack of long-term planning, a parliamentary report has found.
A hematopoietic stem cell transplant, often...